CL2014003146A1 - Método para producir virus arn monocatenario negativo; plásmido recombinante funcional en células animales, que consta de un esqueleto pss-urg; método de obtención de partículas virales; y uso para expresar arn, proteínas autógenas o exógenas al virus. - Google Patents

Método para producir virus arn monocatenario negativo; plásmido recombinante funcional en células animales, que consta de un esqueleto pss-urg; método de obtención de partículas virales; y uso para expresar arn, proteínas autógenas o exógenas al virus.

Info

Publication number
CL2014003146A1
CL2014003146A1 CL2014003146A CL2014003146A CL2014003146A1 CL 2014003146 A1 CL2014003146 A1 CL 2014003146A1 CL 2014003146 A CL2014003146 A CL 2014003146A CL 2014003146 A CL2014003146 A CL 2014003146A CL 2014003146 A1 CL2014003146 A1 CL 2014003146A1
Authority
CL
Chile
Prior art keywords
arn
virus
urg
autogenous
pss
Prior art date
Application number
CL2014003146A
Other languages
English (en)
Inventor
San Martín Marcelo Cortez
Ascuy Daniela Toro
Zamorano Carolina Tambley
Pavez Carolina Beltrán
Ossa Eugenio Spencer
Original Assignee
Univ Santiago Chile
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Santiago Chile filed Critical Univ Santiago Chile
Priority to CL2014003146A priority Critical patent/CL2014003146A1/es
Publication of CL2014003146A1 publication Critical patent/CL2014003146A1/es
Priority to EP16723238.8A priority patent/EP3222730B8/en
Priority to US15/528,328 priority patent/US10544398B2/en
Priority to MX2017006671A priority patent/MX2017006671A/es
Priority to CA2968430A priority patent/CA2968430C/en
Priority to PCT/CL2016/050002 priority patent/WO2016077938A1/es
Priority to BR112017010630-2A priority patent/BR112017010630A2/pt
Priority to DK16723238.8T priority patent/DK3222730T3/da
Priority to CN201680006549.9A priority patent/CN107532180A/zh
Priority to AU2016203557A priority patent/AU2016203557B2/en
Priority to RU2017121232A priority patent/RU2708151C2/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16041—Use of virus, viral particle or viral elements as a vector
    • C12N2760/16043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16051—Methods of production or purification of viral material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16151—Methods of production or purification of viral material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16151—Methods of production or purification of viral material
    • C12N2760/16152—Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/10—Plasmid DNA
    • C12N2800/106—Plasmid DNA for vertebrates
    • C12N2800/107—Plasmid DNA for vertebrates for mammalian
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/80—Vector systems having a special element relevant for transcription from vertebrates

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
CL2014003146A 2014-11-20 2014-11-20 Método para producir virus arn monocatenario negativo; plásmido recombinante funcional en células animales, que consta de un esqueleto pss-urg; método de obtención de partículas virales; y uso para expresar arn, proteínas autógenas o exógenas al virus. CL2014003146A1 (es)

Priority Applications (11)

Application Number Priority Date Filing Date Title
CL2014003146A CL2014003146A1 (es) 2014-11-20 2014-11-20 Método para producir virus arn monocatenario negativo; plásmido recombinante funcional en células animales, que consta de un esqueleto pss-urg; método de obtención de partículas virales; y uso para expresar arn, proteínas autógenas o exógenas al virus.
RU2017121232A RU2708151C2 (ru) 2014-11-20 2016-01-06 Плазмиды и способ получения вирусных частиц
CA2968430A CA2968430C (en) 2014-11-20 2016-01-06 Plasmids and method for obtaining viral particles
US15/528,328 US10544398B2 (en) 2014-11-20 2016-01-06 Plasmids and method for obtaining viral particles
MX2017006671A MX2017006671A (es) 2014-11-20 2016-01-06 Plásmidos y método para obtener partículas virales.
EP16723238.8A EP3222730B8 (en) 2014-11-20 2016-01-06 Plasmids and method for obtaining viral particles
PCT/CL2016/050002 WO2016077938A1 (es) 2014-11-20 2016-01-06 Plásmidos y método para obtener partículas virales
BR112017010630-2A BR112017010630A2 (pt) 2014-11-20 2016-01-06 plasmídeos e método para obter partículas virais
DK16723238.8T DK3222730T3 (da) 2014-11-20 2016-01-06 Plasmider og fremgangsmåde til opnåelse af virale partikler
CN201680006549.9A CN107532180A (zh) 2014-11-20 2016-01-06 用于获得病毒颗粒的质粒和方法
AU2016203557A AU2016203557B2 (en) 2014-11-20 2016-01-06 Plasmids and method for obtaining viral particles

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CL2014003146A CL2014003146A1 (es) 2014-11-20 2014-11-20 Método para producir virus arn monocatenario negativo; plásmido recombinante funcional en células animales, que consta de un esqueleto pss-urg; método de obtención de partículas virales; y uso para expresar arn, proteínas autógenas o exógenas al virus.

Publications (1)

Publication Number Publication Date
CL2014003146A1 true CL2014003146A1 (es) 2015-06-12

Family

ID=56013004

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2014003146A CL2014003146A1 (es) 2014-11-20 2014-11-20 Método para producir virus arn monocatenario negativo; plásmido recombinante funcional en células animales, que consta de un esqueleto pss-urg; método de obtención de partículas virales; y uso para expresar arn, proteínas autógenas o exógenas al virus.

Country Status (11)

Country Link
US (1) US10544398B2 (es)
EP (1) EP3222730B8 (es)
CN (1) CN107532180A (es)
AU (1) AU2016203557B2 (es)
BR (1) BR112017010630A2 (es)
CA (1) CA2968430C (es)
CL (1) CL2014003146A1 (es)
DK (1) DK3222730T3 (es)
MX (1) MX2017006671A (es)
RU (1) RU2708151C2 (es)
WO (1) WO2016077938A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112017020690A2 (pt) 2015-03-30 2018-06-26 Greenlight Biosciences Inc produção livre de células de ácido ribonucleico
CA3020312A1 (en) 2016-04-06 2017-10-12 Greenlight Biosciences, Inc. Cell-free production of ribonucleic acid
KR102894284B1 (ko) 2017-10-11 2025-12-03 그린라이트 바이오사이언시스, 아이엔씨. 뉴클레오시드 트리포스페이트 및 리보핵산 생산을 위한 방법 및 조성물
US20210254103A1 (en) * 2018-07-02 2021-08-19 Voyager Therapeutics, Inc. Treatment of amyotrophic lateral sclerosis and disorders associated with the spinal cord
EP4077355A1 (en) * 2019-12-20 2022-10-26 Intervet International B.V. Reassorted isa virus
AU2023343614A1 (en) * 2022-09-16 2025-05-01 Gmg Fish Services Inc. Vaccines against infectious salmon anemia and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2278621T5 (es) * 1999-07-14 2011-02-02 Mount Sinai School Of Medicine Of New York University Reconstrucción in vitro de virus arn segmentados de polaridad negativa.
TWI477602B (zh) * 2006-02-09 2015-03-21 Educational Foundation Jichi Medical Univ Novel viral vector
EP1867725A1 (en) 2006-06-16 2007-12-19 Institut National De La Recherche Agronomique (Inra) Recombinant novirhabdoviruses and uses thereof

Also Published As

Publication number Publication date
BR112017010630A2 (pt) 2018-02-14
MX2017006671A (es) 2018-11-09
AU2016203557A1 (en) 2017-06-15
US10544398B2 (en) 2020-01-28
DK3222730T3 (da) 2022-01-31
EP3222730B8 (en) 2022-02-23
EP3222730A4 (en) 2018-06-20
CA2968430C (en) 2023-11-07
EP3222730A1 (en) 2017-09-27
CN107532180A (zh) 2018-01-02
US20180030416A1 (en) 2018-02-01
EP3222730B1 (en) 2021-10-27
RU2708151C2 (ru) 2019-12-05
RU2017121232A (ru) 2018-12-20
RU2017121232A3 (es) 2018-12-20
CA2968430A1 (en) 2016-05-26
WO2016077938A1 (es) 2016-05-26
AU2016203557B2 (en) 2022-02-24

Similar Documents

Publication Publication Date Title
IL276679B (en) Cells reject viruses and their uses
IL285972B (en) Bee-ingestible compositions, methods of using same for producing honey and honey produced thereby
Duan et al. Periodicity and dissipativity for memristor-based mixed time-varying delayed neural networks via differential inclusions
IL261665A (en) Aav production in insect cells, methods and compositions therefor
MX395524B (es) Proteinas de cápside modificadas para un suministro mejorado de vectores de parvovirus.
CL2014003146A1 (es) Método para producir virus arn monocatenario negativo; plásmido recombinante funcional en células animales, que consta de un esqueleto pss-urg; método de obtención de partículas virales; y uso para expresar arn, proteínas autógenas o exógenas al virus.
IL252970A0 (en) Compositions and methods for high efficiency in vivo genome editing
HK1255192A1 (zh) 表达细胞因子和羧酸酯酶的修饰的溶瘤痘苗病毒及其使用方法
MX2017007196A (es) Fibroblastos de embrion de pollo inmortalizados.
EP3458485A4 (en) INTERLEUKINE-2 LINKED TO ITS RECEIVER IL-2RBETA, A PLATFORM FOR IMPROVING THE ACTIVITY OF NATURAL KILLER CELLS AND REGULATORY T CELLS
MX382518B (es) Antigenos de citomegalovirus y su uso.
UY35407A (es) ?PROTEÍNAS DE FUSIÓN COMPRENDIENDO PORCIONES PDGF y VEGF DE UNIÓN Y MÉTODOS PARA SU USO?.
IL264454A (en) Novel compositions, uses and methods for making them
PL3123014T3 (pl) Architektura układu napędowego śmigłowca wielosilnikowego oraz śmigłowiec
IL247458A0 (en) Methods and compositions for increasing a t-effector cell to regulatory t cell ratio
IL250203B (en) Method for positioning, in cytoplasm, antibody having complete immunoglobulin form by penetrating antibody through cell membrane, and use for same
EP3215602A4 (en) Methods and materials for producing recombinant viruses in eukaryotic microalgae
BR112017023131A2 (pt) anticorpos anti- fcrn
EP3154560A4 (en) Methods and materials for increasing viral vector infectivity
HUE065661T2 (hu) Kutya parvovírus (CPV) vírusszerû részecske (VLP) vakcinák és alkalmazásuk
EP3194595A4 (en) Viral rna segments as immunomodulatory agents and vaccine components
BR112016019868A2 (pt) proteínas de fusão tatk-cdkl5, composições, formulações, e seu uso
EP3218397B8 (en) Neutralizing antibodies to ebola virus glycoprotein and their use
IL260858B (en) Mesenchymal stem cells as vaccine adjuvants and methods for using the same
Luo Nonvanishing of the central L-values with large weight